文献速递心脑血管急症呼吸衰竭与机械通气重症综合管理与镇静镇痛

癌症患者肺栓塞相关死亡率趋势

Pulmonary Embolism-Related Mortality in Patients With Cancer.
PubMed 文献 · JAMA Netw Open · 2025-02-03
一句话结论2011至2020年美国癌症患者肺栓塞相关年龄标化死亡率上升(AAPC 2.5%,95%CI 1.4%–3.6%,P=.001),15–64岁人群、部分种族及南部地区上升更明显。

该队列研究利用美国CDC WONDER数据系统,分析2011年1月至2020年12月美国15岁及以上癌症患者急性肺栓塞相关年龄标化死亡率(AAMR)的全国趋势,并从美国癌症统计获取同期癌症死亡率与发病率趋势。结果显示,癌症患者肺栓塞相关AAMR上升(AAPC 2.5%;95%CI 1.4%–3.6%;P=.001),两性间无差异(平行性P=.38)。15–64岁人群(AAPC 3.2%;95%CI 1.9%–4.6%;P=.001)、非西班牙裔和非拉丁裔白人(AAPC 2.7%;95%CI 1.52%–3.94%;P=.001)、非西班牙裔和非拉丁裔黑人/非洲裔美国人(AAPC 2.2%;95%CI 0.7%–3.7%;P=.001)、西班牙裔和拉丁裔人群(AAPC 2.6%;95%CI 0.7%–4.5%;P=.006)及美国南部居民(AAPC 3.7%;95%CI 1.3%–6.2%;P=.003)的AAMR上升。同期年龄标化癌症发病率和癌症相关死亡率下降,但新发癌症诊断和癌症相关死亡的绝对数增加。作者认为识别这些模式可为癌症及其治疗并发症肺栓塞的血栓预防和治疗研究提供信息。

要点

  • 2011至2020年美国癌症患者肺栓塞相关年龄标化死亡率上升(AAPC 2.5%;95%CI 1.4%–3.6%;P=.001)。
  • 15–64岁癌症患者肺栓塞相关死亡率上升(AAPC 3.2%;95%CI 1.9%–4.6%;P=.001)。
  • 美国南部癌症患者肺栓塞相关死亡率上升(AAPC 3.7%;95%CI 1.3%–6.2%;P=.003)。
  • 非西班牙裔和非拉丁裔白人、非西班牙裔和非拉丁裔黑人/非洲裔美国人、西班牙裔和拉丁裔癌症患者肺栓塞相关死亡率均上升。
  • 同期年龄标化癌症发病率和癌症相关死亡率下降,但新发癌症诊断和癌症相关死亡绝对数增加。

适用人群与场景

  • 2011年1月至2020年12月美国15岁及以上癌症患者,数据来自CDC WONDER数据系统。

研究设计与关键结果

  • 研究类型为队列研究,使用CDC WONDER数据系统分析2011年1月至2020年12月美国15岁及以上癌症患者急性肺栓塞相关年龄标化死亡率趋势,同期癌症死亡率与发病率来自美国癌症统计。
  • 2011至2020年美国15岁及以上人群死亡总数为27 280 194例(男性13 897 519例[50.9%];女性13 382 675例[49.1%])。
  • 癌症患者肺栓塞相关年龄标化死亡率上升(AAPC 2.5%;95%CI 1.4%–3.6%;P=.001),两性间无差异(平行性P=.38)。
  • 15–64岁人群肺栓塞相关年龄标化死亡率上升(AAPC 3.2%;95%CI 1.9%–4.6%;P=.001)。
  • 非西班牙裔和非拉丁裔白人肺栓塞相关年龄标化死亡率上升(AAPC 2.7%;95%CI 1.52%–3.94%;P=.001);非西班牙裔和非拉丁裔黑人/非洲裔美国人上升(AAPC 2.2%;95%CI 0.7%–3.7%;P=.001);西班牙裔和拉丁裔人群上升(AAPC 2.6%;95%CI 0.7%–4.5%;P=.006)。
  • 居住在美国南部的癌症患者肺栓塞相关年龄标化死亡率上升(AAPC 3.7%;95%CI 1.3%–6.2%;P=.003)。
  • 同期年龄标化癌症发病率和癌症相关死亡率下降,但新发癌症诊断和癌症相关死亡的绝对数增加。

证据类型、等级与局限

  • 证据类型:队列研究,使用CDC WONDER数据系统。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,识别癌症患者肺栓塞相关死亡率在年轻人群、特定种族和民族群体及美国南部地区上升的模式,可为癌症及其治疗并发症肺栓塞的血栓预防和治疗进一步研究提供信息。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Acute pulmonary embolism (PE) is a major cause of morbidity and mortality in patients with cancer in the US and worldwide.

OBJECTIVES: To assess the trends in PE-related mortality from 2011 to 2020 among US patients with cancer across age, sex, ethnic and racial groups, urbanicity, and regionality.

DESIGN, SETTING, AND PARTICIPANTS: This cohort study used the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research data system to determine national trends in age-adjusted mortality rates (AAMRs) due to acute PE among US patients with cancer aged 15 years or older from January 2011 to December 2020. Concomitant trends in cancer mortality and incidence that may have contributed to PE-related mortality were obtained from US Cancer Statistics. Data were analyzed from September to November 2024.

EXPOSURE: PE-related mortality.

MAIN OUTCOMES AND MEASURES: The primary outcome was PE-related deaths among individuals with cancer. AAMRs and cancer incidence were assessed using joinpoint regression modeling, expressed as an average annual percentage change (AAPC) with relative 95% CIs.

RESULTS: From 2011 to 2020, a total of 27 280 194 individuals aged 15 years or older (13 897 519 male [50.9%]; 13 382 675 female [49.1%]) died in the US. The AAMR for PE-related mortality in patients with cancer increased during this time period (AAPC, 2.5%; 95% CI, 1.4% to 3.6%; P = .001), without differences between sexes (P for parallelism = .38). The AAMR increased among those aged 15 to 64 years (AAPC, 3.2%; 95% CI, 1.9% to 4.6%; P = .001), non-Hispanic and non-Latinx White individuals (AAPC, 2.7%; 95% CI, 1.52% to 3.94%; P = .001), non-Hispanic and non-Latinx Black or African American individuals (AAPC, 2.2%; 95% CI, 0.7% to 3.7%; P = .001), Hispanic and Latinx individuals (AAPC, 2.6%; 95% CI, 0.7% to 4.5%; P = .006), and among individuals residing in the Southern US (AAPC, 3.7%; 95% CI, 1.3% to 6.2%; P = .003). During the same period, age-adjusted cancer incidence and cancer-related mortality decreased while the absolute number of new cancer diagnoses and cancer-related deaths increased.

CONCLUSIONS AND RELEVANCE: This cohort study found that despite decreases in cancer-related mortality rates, age-adjusted PE-related mortality in US patients with cancer increased over the last decade; concerning trends included rising PE-related mortality in younger individuals aged 15 to 64 years, particular ethnic and racial groups, and the Southern region of the US. Recognition of such patterns may inform further research into thromboprophylaxis and treatment of PE as a complication of cancer and cancer-directed therapy.

来源:JAMA Netw Open,查看原文。版权归原作者所有。

参考来源

  1. Zuin M, Nohria A, Henkin S, et al. Pulmonary Embolism-Related Mortality in Patients With Cancer. JAMA Netw Open. 2025. PMID: 39964681. doi:10.1001/jamanetworkopen.2024.60315

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。